Neil F. Mcfarlane - Net Worth and Insider Trading
Neil F. Mcfarlane Net Worth
The estimated net worth of Neil F. Mcfarlane is at least $242,352 dollars as of 2024-08-25. Neil F. Mcfarlane is the COO of Travere Therapeutics Inc and owns about 26,988 shares of Travere Therapeutics Inc (TVTX) stock worth over $242,352. Details can be seen in Neil F. Mcfarlane's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Neil F. Mcfarlane has not made any transactions after 2019-05-16 and currently still holds the listed stock(s).
Transaction Summary of Neil F. Mcfarlane
Neil F. Mcfarlane Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Neil F. Mcfarlane owns 4 companies in total, including Adamas Pharmaceuticals Inc (ADMS) , Travere Therapeutics Inc (TVTX) , and Collegium Pharmaceutical Inc (COLL) among others .
Click here to see the complete history of Neil F. Mcfarlane’s form 4 insider trades.
Insider Ownership Summary of Neil F. Mcfarlane
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ADMS | Adamas Pharmaceuticals Inc | 2020-03-18 | Chief Executive Officer |
TVTX | Travere Therapeutics Inc | 2019-05-16 | Chief Operating Officer |
COLL | Collegium Pharmaceutical Inc | 2022-04-06 | director |
![]() | ![]() | 2023-10-10 | director & President and CEO |
Neil F. Mcfarlane Latest Holdings Summary
Neil F. Mcfarlane currently owns a total of 1 stock. Neil F. Mcfarlane owns 26,988 shares of Travere Therapeutics Inc (TVTX) as of May 16, 2019, with a value of $242,352.
Latest Holdings of Neil F. Mcfarlane
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TVTX | Travere Therapeutics Inc | 2019-05-16 | 26,988 | 8.98 | 242,352 |
Holding Weightings of Neil F. Mcfarlane
Neil F. Mcfarlane Form 4 Trading Tracker
According to the SEC Form 4 filings, Neil F. Mcfarlane has made a total of 0 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years. The most-recent trade in Travere Therapeutics Inc is the sale of 1,968 shares on May 16, 2019, which brought Neil F. Mcfarlane around $35,916.
Insider Trading History of Neil F. Mcfarlane
- 1
Neil F. Mcfarlane Trading Performance
Neil F. Mcfarlane Ownership Network
Ownership Network List of Neil F. Mcfarlane
Ownership Network Relation of Neil F. Mcfarlane
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Neil F. Mcfarlane Owned Company Details
What does Adamas Pharmaceuticals Inc do?
Who are the key executives at Adamas Pharmaceuticals Inc?
Neil F. Mcfarlane is the Chief Executive Officer of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .
Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adamas Pharmaceuticals Inc Insider Transactions
Neil F. Mcfarlane Mailing Address
Above is the net worth, insider trading, and ownership report for Neil F. Mcfarlane. You might contact Neil F. Mcfarlane via mailing address: C/o Retrophin, Inc., 12255 El Camino Real, Suite 250, San Diego Ca 92130.